Announcements
4 December 2025
Biomedicines | Editor’s Choice Articles Published in 2023–2024 and Hot Topic Special Issues in the “Molecular Genetics and Genetic Diseases” Section
We are delighted to share a collection of Editor’s Choice Articles in the Section “Molecular Genetics and Genetic Diseases” that were published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) from 2023 to 2024. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:
The list of relevant papers can be seen below:
1. “Sensitivity Analysis for Survival Prognostic Prediction with Gene Selection: A Copula Method for Dependent Censoring”
by Chih-Tung Yeh, Gen-Yih Liao and Takeshi Emura
Biomedicines 2023, 11(3), 797; https://doi.org/10.3390/biomedicines11030797
Available online: https://www.mdpi.com/2227-9059/11/3/797
2. “Targeted DNA Demethylation: Vectors, Effectors and Perspectives”
by Naohiro Yano and Alexey V. Fedulov
Biomedicines 2023, 11(5), 1334; https://doi.org/10.3390/biomedicines11051334
Available online: https://www.mdpi.com/2227-9059/11/5/1334
3. “Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update”
by Iulia Lupan, Vasile Bintintan, Diana Deleanu, and Gabriel Samasca
Biomedicines 2024, 12(9), 2001; https://doi.org/10.3390/biomedicines12092001
Available online: https://www.mdpi.com/2227-9059/12/9/2001
4. “STAT3 Protein–Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes”
by Gautam Kundu, Maryam Ghasemi, Seungbin Yim, Ayanna Rohil, Cuiyan Xin, Leo Ren, Shraddha Srivastava, Akinwande Akinfolarin, Subodh Kumar, Gyan P. Srivastava et al.
Biomedicines 2024, 12(9), 2102; https://doi.org/10.3390/biomedicines12092102
Available online: https://www.mdpi.com/2227-9059/12/9/2102
Special Issues:
|
1. “Cancer Genetics: Bench-to-Bedside Advances” |
2. “Advanced Single-Cell Sequencing in Diseases” |
|
|
|
|
3. “Hereditary Diseases: Insights from Genetic Perspectives” |
4. “Current Status and Future Directions of Molecular Genetics and Genetic Diseases” |
|
|
|
|
5. “Genome Engineering Technologies for Diseases” |
6. “Technologies and Applications of Genome Editing” |
|
|
|
Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This “Molecular Genetics and Genetic Diseases” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.
Biomedicines Editorial Office
24 November 2025
Editorial Board Members from Biomedicines Featured in the 2025 Highly Cited Researchers List Published by Clarivate
18 November 2025
Biomedicines Webinar | Morpho-Molecular and Genetic Basis of Cardiomyopathies, 11 December 2025
Cardiomyopathies include several heart muscle diseases that are often incompletely defined in terms of cause and pathway and often poorly responsive to the proposed treatment. Even in largely recognized entities such as myocarditis, the adoption of the effective therapy is still debated and the agents involved are being increasingly identified by the new-generation sequencing technique. In fact, the morphomolecular investigation of endomyocardial biopsy samples appears to be inevitable to obtain a personalized and most effective treatment.
Regarding the origin of cardiac electrical instability, the direct involvement of conduction tissue (CT) is recognizable in endomyocardial biopsy examination and the possibility to explore CT damage through the determination of CT main molecular complex HCN4 in the peripheral blood appears as a likely prospective option. Many rare diseases phenotyipically present as cardiomyopathies and their definition and identification are crucial for appropriate management.
Nevertheless, even the administration of the lacking molecular component (i.e., enzyme replacement therapy—ERT) can be clinically unsatisfactory. Recently, it has been shown that ERT delivery can be limited in Fabry disease cardiomyopathy by a reduced expression of mannose-6-phosphate receptor that provides its uptake at the level of cell membrane as well as its targeting into lysosomes.
The aim of the present webinar is to update the latest morpho-molecular and genetic knowledge in cardiomyopathy.
Date: 11 December 2025
Time: 2:00 p.m. CET | 8:00 a.m. EST | 9:00 p.m. CST Asia
Webinar ID: 875 7695 1210
Website: https://sciforum.net/event/Biomedicines-19
Register now for free!
| Speaker/Presentation | Time in CET | Time in EST | Time in CST Asia |
| Prof. Dr. Andrea Frustaci Chair Introduction |
2:00–2:10 p.m. | 8:00–8:10 a.m. | 9:00–9:10 p.m. |
| Prof. Dr. Andrea Frustaci Morpho-Molecular Substrate of Resistance to Enzyme Replacement Therapy in Fabry Disease Cardiomyopathy |
2:10–2:30 p.m. | 8:10–8:30 a.m. | 9:10–9:30 p.m. |
| Prof. Dr. Heinz-Peter Schultheis Diagnosis and Treatment of Viral Inflammatory Cardiomyopathy |
2:30–2:50 p.m. | 8:30–8:50 a.m. | 9:30–9:50 p.m. |
| Prof. Dr. Matteo Antonio Russo Electron-Microscopy in Human Cardiomyopathies |
2:50–3:10 p.m. | 8:50–9:10 a.m. | 9:50–10:10 p.m. |
| Prof. Dr Alessandro De Luca Novel Genetic Contributes to Characterization of Cardiomyopathies |
3:10–3:30 p.m. | 9:10–9:30 a.m. | 10:10–10:30 p.m. |
| Q&A Session | 3:30–3:45 p.m. | 9:30–9:45 a.m. | 10:30–10:45 p.m. |
| Prof. Dr. Andrea Frustaci Closing of Webinar |
3:45–3:50 p.m. | 9:45–9:50 a.m. | 10:45–10:50 p.m. |
After registering, you will receive a confirmation email outlining how to join this webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Prof. Dr. Andrea Frustaci, Cellular and Molecular Cardiology Lab, National Institute for Infectious Diseases L. Spallanzani, Rome, Italy;
- Prof. Dr. Heinz-Peter Schultheiss, Institut Kardiale Diagnostik und Therapie (IKDT), Berlin, Germany;
- Prof. Dr. Matteo Antonio Russo, IRCCS San Raffaele Rome, Italy;
- Prof. Dr. Alessandro De Luca, Medical Genetics Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Relevant Special Issue:
“Morpho-Molecular and Genetic Basis of Cardiomyopathies”
Guest Editor: Prof. Dr. Andrea Frustaci
Deadline for manuscript submissions: 30 June 2026
11 November 2025
Meet Us at the Pharmacology 2025, 16–18 December 2025, Belfast, UK
6 November 2025
Biomedicines | Interview with One of the Authors of a Highly Cited Paper—Dr. Yoon Jae Lee
Dr. Yoon Jae Lee is one of the authors of the highly cited article entitled “The Role of Adipokines in Tumor Progression and Its Association with Obesity” published in Biomedicines (ISSN: 2227-9059).
The following is an interview with Dr. Lee:
- Congratulations on your published paper! Could you please briefly introduce the main research content of the published paper?
Our review explores how adipokines—bioactive molecules secreted by adipose tissue—serve as key mediators linking obesity to tumorigenesis. We summarize the molecular mechanisms through which specific adipokines such as leptin, adiponectin, visfatin, resistin, apelin, and chemerin influence cancer initiation, progression, and metastasis. The paper also emphasizes the crosstalk between adipokines, tumor cells, and the tumor microenvironment (TME), highlighting how dysregulated adipokine signaling promotes inflammation, angiogenesis, and metabolic reprogramming conducive to tumor growth. Finally, we discuss the therapeutic potential of targeting adipokine pathways as a novel strategy for obesity-associated cancers. - Can you tell us a little bit about yourself and your current research?
I am a plastic and reconstructive surgeon and an assistant professor working at Yeouido St. Mary’s Hospital, The Catholic University of Korea. My current research focuses on wound healing, adipose biology, and regenerative medicine, with particular interest in how adipose-derived factors modulate tissue repair and carcinogenesis. Our team is also developing translational models using decellularized extracellular matrices and cell-based composite grafts to better understand the intersection between inflammation, fibrosis, and tumor progression. - Would you mind sharing what inspired your research?
This work was inspired by my dual clinical and research experience. As a reconstructive surgeon, I frequently observe how adipose tissue behaves in healing and pathological contexts. The growing evidence that obesity influences cancer biology through endocrine signaling encouraged our team to synthesize emerging data on adipokines. We wanted to provide clinicians and researchers with a comprehensive framework explaining how adipose-derived molecules could act as both pathological drivers and therapeutic targets in cancer. - What was the biggest challenge you faced while writing this paper, and how did you overcome it?
The most significant challenge was integrating heterogeneous data from multiple cancer models and experimental systems. To overcome this, we focused on a systematic synthesis of mechanistic pathways—signal transduction networks such as JAK/STAT, PI3K/Akt, and AMPK/mTOR—and cross-referenced them across cancer types to highlight convergent mechanisms rather than isolated findings. - How did feedback during your research influence your direction?
Peer and collaborator feedback played an essential role. During revision, reviewers encouraged us to expand our discussion of the tumor microenvironment and clarify how adipokine dysregulation impacts immune cell polarization and epithelial–mesenchymal transition (EMT). Incorporating these aspects strengthened the paper’s translational relevance and shifted our focus from isolated adipokine effects to a systemic, microenvironment-centered understanding of obesity-related cancer. - What role did you play in your research team, and how did teamwork affect the paper’s outcome?
As the corresponding author and principal investigator, I oversaw conceptualization, supervision, and final editing. Dr. Jae Won Kim contributed to data curation and literature synthesis. Our collaboration was highly synergistic—my clinical perspective complemented their molecular focus. This interdisciplinary teamwork allowed us to bridge bench research and clinical implications, making the review both mechanistically robust and practically meaningful. - Why did you choose the Biomedicines journal as a platform for publishing your work, and how was your experience?
We chose Biomedicines for its strong focus on translational biomedical research and open-access visibility. The review process was efficient and constructive, providing valuable scientific feedback and a smooth publication experience. - What impact do you hope your research will have, and what key innovation do you see in your paper?
We hope this review will serve as a reference framework for future studies exploring obesity-associated cancers. The key innovation lies in our integrated model of adipokine–tumor interactions, illustrating how endocrine, metabolic, and immune pathways converge to promote tumor progression. By framing adipokines not merely as biomarkers but as active modulators of the tumor ecosystem, we aim to guide therapeutic research toward adipokine-targeted interventions. - What do you think the future directions for your research are?
We plan to explore how modulating adipokine pathways can control both tumor progression and tissue regeneration. Our goal is to develop translational strategies that bridge adipose biology with cancer prevention and wound-healing therapy.
4 November 2025
MDPI INSIGHTS: The CEO's Letter #28 - WSF11, Nobel Laureates, Proofig AI, Romania Summit, STM and FBF
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Highlights from the 11th World Sustainability Forum in Barcelona
I’m pleased to share some highlights from the 11th World Sustainability Forum (WSF 11), held in Barcelona on 2–3 October 2025 under the theme Sustainable and Resilient Cities.
Why WSF matters
The WSF series is a flagship initiative for MDPI and is supported by the MDPI Sustainability Foundation. It serves as a transdisciplinary platform for researchers, policymakers, and stakeholders to engage on sustainability challenges. WSF is now held annually as part of our commitment to maintain momentum in the sustainability discourse.
|
|
|
|
This year’s Barcelona edition focused on urban resilience, landscape design, and social community impact in the sustainability space. Over 48 hours of sessions, we brought together leading minds across disciplines to translate vision into practice. With participants from 53 countries across all continents, WSF 11 was truly global in scope.
“WSF is now held annually as part of our commitment to maintain momentum in the sustainability discourse”
What made WSF 11 especially successful (from my vantage point) was the level of positive engagement with our participants. Chief editors, researchers, and attendees repeatedly told me how professionally executed the event was, highlighting the high energy, logistical smoothness and quality of MDPI’s event management. That kind of recognition from peers really builds our reputation as more than just a publisher, but as a convener of meaningful scientific dialogue.
Our conferences are a form of experiential marketing as they create memorable and immersive connections between a brand and attendees. These positive associations build promotion and brand loyalty, ultimately impacting the MDPI’s trust and reputation for the better.
WSF 11: By the numbers
Here’s a quick snapshot of WSF 11’s scale and reach:
- 181 registrations across global participants.
- 8 keynote speakers and 5 invited speakers.
- 144 abstracts accepted (over 355 submitted), resulting in 75 short talks and 69 posters.
- 53 countries were represented across all continents, making it a truly international event.
- First time that we ran parallel sessions for WSF (an ambitious program).
- A dedicated awards ceremony to honour outstanding sustainability research: World Sustainability Award (WSA) x 2 winners, and Emerging Sustainability Leader Award (ESLA) x 3 winners.
Interviews with our World Sustainability Award Winners
One of the most rewarding parts of WSF is recognizing researchers whose work advances sustainability in powerful ways. In our Blog series, Daniella Maritan-Thomson (Content Specialist, MDPI) interviewed the two winners of the World Sustainability Award, Professor Dr. Stuart Pimm and Dr. Abdelbagi M. Ismail, who offered insights to the human side of sustainability research, the people behind the data, and the stories behind the science.
|
|
Prof. Stuart Pimm, whose decades of conservation work make him a leader in biodiversity preservation, reflected on his WSF Award experience and research in this interview: [Interview: Prof Stuart Pimm] |
|
|
Dr. Abdelbagi M. Ismail, an expert in crop improvement and winner of the WSF Award, shares his journey and perspectives here: [Interview: Dr Abdelbagi M. Ismail] |
“Our conferences create memorable and immersive connections”
Emerging Sustainability Leader Award winners
Stefan Tochev (CEO, MDPI), Prof. Dr. Vhahangwele Masindi, Dr. Katya Rhodes, and Prof. Dr. Myriam Ertz (left to right).
We also recognized three recipients of the Emerging Sustainability Leader Award: Prof. Dr. Vhahangwele Masindi, Dr. Katya Rhodes, and Prof. Dr. Myriam Ertz, for their contributions as early-career researchers advancing sustainability through innovation, impact, and academic excellence across the field.
What this means for MDPI
- Building our global identity in events
WSF is a marquee MDPI event, not just a gathering, but a statement of how we wish to position ourselves in the global sustainability ecosystem. The positive feedback helps us build on our approach for future editions, so that we remain a reference point for quality, relevance, and engagement. - Expanding capacity across offices
The success of WSF 11 in Barcelona’s would not have happened without great teamwork from Basel, Barcelona, Romania, the UK, and the APAC Conference team. Thanks to everyone for their work to bring this ambitious event to life. - Supporting MDPI’s mission
At this event, I had the opportunity to present on MDPI's role in Open Access, sustainability publishing, and the intersection of science and policy. WSF is not only about the science; it’s also a platform for us to position MDPI as a thought leader and a collaborator in shaping the future of sustainable research.
I look forward to the WSF momentum as we work towards WSF 12 in Hong Kong, which is scheduled for August 2026.
MDPI Colleagues at the 11th World Sustainability Forum in Barcelona, Spain, 2–3 October 2025.
Impactful Research
Celebrating 2025 Nobel Laureates who have published with MDPI
October is always an inspiring month in science. It’s when the world turns its attention to the Nobel Prize announcements, recognizing discoveries that have changed how we understand the world.
Over the years, many distinguished researchers who have received the Nobel Prize have chosen to publish their work with MDPI. These are scientists whose breakthroughs have shaped entire fields of research, and who have entrusted our Open Access journals to share their findings with the world.
“The work we support can be world-class and world-changing”
Congratulations to the 2025 Laureates
Dozens of Nobel Laureates have published in our journals: as at 2024, more than 40 laureates had contributed over 115 articles across more than 35 MDPI journals. Congratulations to the three 2025 Nobel prize-winners who have published with MDPI during their careers. Below are links to their MDPI publications and announcements for further reading:
- Omar M. Yaghi (Chemistry)
- Awarded for his pioneering work on metal-organic frameworks (MOFs). MDPI published his article “Covalent Organic Frameworks: Organic Chemistry Beyond the Molecule” in Molecules (2017).
- MDPI Announcement: https://www.mdpi.com/news/13455
- Nobel Prize in Chemistry – The Science Behind the Prize
- Shimon Sakaguchi (Medicine)
- Recognized for discoveries in immune-system self-tolerance and regulatory T-cells. Published in Cancers (2021).
- MDPI Announcement: https://www.mdpi.com/news/13443
- Nobel Prize in Physiology or Medicine – The Science Behind the Prize
- John M. Martinis (Physics)
- Recognized for quantum tunnelling in electrical circuits. MDPI’s Journal of Nuclear Engineering (2025) includes his co-authored work.
- MDPI Announcement: https://www.mdpi.com/news/13450
- Nobel Prize in Physics – The Science Behind the Prize
These connections strengthen our mission to make research freely available and ensure that transformative ideas reach the widest possible audience.
Publishing at the leading edge of knowledge
The privilege of hosting such contributors resonates deeply with our editorial teams. It shows that top-tier scientific work has a home at MDPI, which builds our visibility in the research community. It signals that our publishing model, our editorial workflows, and our commitment to Open Access are respected at the very highest levels of science. It also gives our authors, reviewers, editors and staff the message that the work we support can be world-class and world-changing.
Publishing at the leading edge of knowledge isn’t just about individual papers – it’s about the ecosystem of support, transparency, and accessibility that makes discovery possible. Let’s continue to build a publishing platform and provide a service that attracts and enables both everyday research and the breakthroughs of tomorrow.
Inside MDPI
Strengthening Research Integrity: MDPI partners with Proofig AI
I’m pleased to share that MDPI has entered a multi-year partnership with Proofig AI, a leader in AI-driven proofing and integrity software for scientific publishing. This follows the success of our pilot program, in which Proofig AI proved highly effective in detecting duplicated, altered, and manipulated images across biomedical submissions.
Safeguarding the credibility of the research we publish
Research integrity is at the core of MDPI’s mission. The life sciences, in particular, face increasing risks of image-related issues due to advanced editing tools and generative AI. By integrating Proofig AI into our workflows, we improve our ability to detect issues early, reduce post-publication corrections, and safeguard the credibility of the research we publish.
Pilot outcomes
- Successful detection of duplicated confocal and histology images, even when altered to disguise similarities.
- Early results showed a significant drop in post-publication image manipulation flags year-on-year.
- Positive feedback from editors and staff highlighted the tool’s ease of use and reliability.
Dr. Dror Kolodkin-Gal (co-founder and CEO of Proofig AI) said:
“The MDPI team conducted a highly professional and carefully monitored pilot, achieving excellent results in detecting problematic images.
Their fast and effective integration process was impressive, and we are excited to contribute to this important collaboration.”
Sanita Meijere (IT Product and Project Manager, MDPI), shared:
“For more than a year, we’ve tested all the available image manipulation detection tools. Proofig AI’s quality and ease of use, alongside positive feedback from our internal users, made their software a clear stand-out.
We’re thrilled to be moving forward with this partnership, ensuring we do our utmost to protect MDPI’s biomedical journals. Using this advanced image proofing software reaffirms MDPI’s commitment to maintaining the highest standards in research integrity.”
Raising the bar for integrity
This partnership sets a new benchmark for quality control in biomedical publishing.
As Tim Tait-Jamieson (Head of Publication Ethics, MDPI), explains:
“The life sciences are disproportionately affected by research integrity issues, making vigilance in this field especially critical. This is driven, in part, by the increasing sophistication of image editing software and generative AI.
Whether accidental or deliberate, image manipulation can have a lasting impact on credibility. By integrating Proofig AI into our editorial workflows, we strengthen our ability to detect scientific misconduct early and reduce post-publication amendments.”
Faster and more accurate quality control
Proofig will automatically flag potentially problematic images during submission checks, giving our editors more confidence in the integrity of manuscripts and freeing up time to focus on editorial decisions. The tool will also reduce the burden of manual checks, while supporting faster and more accurate quality control. This partnership reinforces MDPI's reputation as a publisher that takes integrity seriously and continues to invest in tools to support authors, editors, and reviewers alike.
A big thank-you to all colleagues who supported the pilot and rollout. You can read more in our MDPI Blog post.
Coming Together for Science
The MDPI Romania Summit 2025
On 21–22 October, I had the pleasure of joining our colleagues in Bucharest for the MDPI Romania Summit 2025. The event was organized by our Romania Marketing team, with support from colleagues across our Romanian offices. It brought together academics, policymakers, and collaborators to discuss the country’s evolving research landscape.
Over two days, we welcomed more than 30 participants, including Editorial Board Members, Guest Editors, and policy-makers from the Romanian research and education sectors, including representatives from the Romanian Academy and the National Commission for the Accreditation of Academic Titles (CNATDCU).
The discussions and presentations reflected the strength and growth of Romania’s research community and its active engagement in Open Access publishing.
|
|
|
|
“The discussions and presentations reflected the strength and growth of Romania’s research community”
Romania’s role in Open Access
Romania loves Open Access and has emerged as one of MDPI’s most engaged national research communities. The numbers speak for themselves:
- 67% of all publications in Romania were Open Access in 2024.
- MDPI accounts for 39% of the country’s total OA publications (14,779 in 2024).
- Over the last five years (2020–2024), Romanian institutions published over 33,000 papers with MDPI.
- There are 460 active Editorial Board Members from Romania, including 8 Chief Editors.
- 29 institutions are part of our Institutional Open Access Program (IOAP), with 8 new members joining in 2025.
These numbers reflect the trust and reliable partnership we have built with the Romanian academic community.
Highlights from the Summit
The program covered a wide range of topics from MDPI’s achievements and updates to our editorial processes, peer-review quality, AI in publishing, IOAP and Open Access funding models, and publication ethics.
|
|
|
|
|
|
|
|
Agenda Highlights:
- MDPI Introduction, Performance & Achievements, and Collaboration with Romania – Stefan Tochev (CEO, MDPI).
- Trust the Process: Editorial Workflow and Quality in Publishing – Dr. Liliane Auwerter (Scientific Review Group).
- Publication Ethics at MDPI: Safeguarding the Integrity of the Published Scholarly Record – Diana Cristina Apodaritei (Research Integrity Specialist).
- Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI).
- AI in Publishing and MDPI's Actions – Sanita Meijere (AI Product Manager).
- Closing Remarks – Stefan Tochev (CEO, MDPI).
Participants shared feedback and ideas for future collaborations, including organizing author workshops, possible conference collaborations, and strengthening our engagement with national institutions such as the Ministry of Education and Research and the National Council of Romanian Rectors.
As Acad. Dr. Nicolae-Victor Zamfir, Vice President of the Romanian Academy, noted during the discussions:
“The organization of the event is very timely, because MDPI is a publishing house in full development and expansion. The opinion of researchers is important for increasing the quality of published works.”
A collaborative future
Events like this remind us how essential it is to engage locally and listen directly to the voices of our editors, authors, and institutional partners. They help us build relationships, improve our understanding of the local market, and align our shared goals in advancing Open Access and research quality.
Thank you to everyone involved, especially our Romania Marketing team, who organized the event, and to all colleagues who continue to build relationships with our academic communities around the world.
Thank you!
A special thank-you to the Romanian Marketing team and all colleagues behind the scenes who made this Summit such a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.
Closing Thoughts
STM and FBF 2025: Connecting Through Science and Publishing
Stefan Tochev (CEO, MDPI), Constanze Schelhorn (Head of Indexing, MDPI) at STM Conference, Frankfurt, 14 October 2025.
On 13–14 October, I attended the STM Frankfurt Conference 2025, my fourth visit to the Frankfurt event, and it continues to be one of the most valuable gatherings in our industry.
The STM meeting brings together the publishing community and key opinion leaders to speak on current trends and challenges shaping our industry.
This year’s theme – “Science Diplomacy: What is it and How Does it Work?” – unpacked the growing intersection of science, policy, and publishing.
Discussion topics ranged from what is science diplomacy and how publishers can contribute to global collaboration to how science communication can help maintain trust during an era of disruption.
I was joined by Dr. Constanze Schelhorn, our Head of Indexing, who met with representatives from Scopus, Web of Science, Digital Science, ProQuest, and other partners. These meetings give us a chance to share feedback on our collaborations, learn about new updates being developed, and build our relationships with indexing bodies.
“The STM meeting brings together the publishing community and key opinion leaders”
STM also provides a space to connect with industry peers, as I did with colleagues from Elsevier, Frontiers, Clarivate, Sage, and STM itself, reinforcing MDPI’s engagement within the broader publishing community. It was also nice to bump into some former colleagues and see them continuing to grow in their publishing careers.
At the Frankfurt Book Fair
The MDPI booth at the 2025 Frankfurt Book Fair.
Following STM, I spent the next day at the Frankfurt Book Fair (15–19 October) – one of the largest and most influential events in the publishing world.
It’s always inspiring to see the scale and energy of this global gathering, which spans everything from books and education to digital innovation and academic publishing.
We set up an MDPI booth to host discussions with partners, vendors, and researchers.
The Fair ran into the weekend, with colleagues from several MDPI departments attending to represent the company and connect with the scholarly community.
Events like STM and FBF are a nice reminder of how dynamic and interconnected our industry is, and how important it is for MDPI to continue taking part in global conversations about science, communication, and the future of publishing.
Chief Executive Officer
MDPI AG
15 October 2025
MDPI’s Newly Launched Journals in September 2025
Nine new journals covering a range of subjects launched their inaugural issues in September 2025. We are excited to be able to share with you the newest research rooted in the value of open access.
We extend our sincere thanks to all Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
Journal |
Founding Editor-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Joseph G. Grzywacz, San José State University, USA |
family formation and dynamics; family relationships; family diversity and structure; family processes; family challenges; global perspectives of family | |
|
|
Prof. Dr. Chengkuo Lee, National University of Singapore, Singapore |
AIoT sensing technologies; distributed AI and federated learning; AI-enhanced edge analytics; sensor fusion in edge computing; low-power AI sensing; security and privacy in edge-AI systems; AI-driven optimization of IoT networks | |
|
|
Prof. Dr. Steven Paul Nistico, Sapienza University of Rome, Italy |
aesthetics; reconstructive surgery and plastic surgery; dermatology; oral and maxillofacial surgery; surgical procedures; non-surgical procedures | |
|
|
Prof. Dr. Mauro Tonelli, University of Pisa, Italy |
plasma physics and technology; atomic and molecular physics; nuclear physics; quantum physics and technology; dielectrics, ferroelectrics, and multiferroics; semiconductor physics and devices; engineering physics; material physics; biophysics| |
|
|
Prof. Dr. Sergej M. Ostojic, University of Agder, Norway; |
biochemical research methods; biochemistry and molecular biology; cell biology; clinical and medicinal chemistry; clinical neurology; endocrinology and metabolism; medicine, general and internal; nutrition and dietetics; toxicology | |
|
|
Prof. Dr. Michele Nappi, University of Salerno, Italy |
foundations and advancements in multimedia technologies; computational social media analytics; human–AI interaction in social contexts; multimedia understanding and generation for social insight; ethics, fairness, and privacy in multimedia systems | |
|
|
Prof. Dr. Philippe Gorce, Toulon University, France |
ergonomic design and evaluation of workspaces, tools, and equipment; biomechanical analysis and ergonomic interventions for musculoskeletal health; cognitive workload assessment and management; human-computer interaction (HCI) and user experience (UX) research; ergonomic wearables; AI-driven ergonomic assessment tools; neuroergonomics | |
|
|
Prof. Dr. Ronald Charles Sims, Utah State University, USA |
bioresources; bioproducts; bioenergy and biofuels; environmental protection; public health protection; biological waste treatment; biomass transformation; circular bioeconomy; bio-based materials and chemicals; bioresidues | |
|
|
Prof. Dr. M. Jamal Deen, McMaster University, Canada |
device design and engineering; circuit design and system integration; applications and emerging technologies; materials and fabrication innovations; testing, reliability, and standards | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create more new journals, you are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com).
15 October 2025
Biomedicines Webinar | Extracellular Vesicles in Health and Disease, 30 October 2025
Extracellular vesicles are nano particles secreted virtually from all cell types across all organisms. They contain thousands of molecules that, upon secretion and engulfment in recipient bystander cells, affect the phenotype of the recipient cells. Recently, scientific interest in these vesicles is increasing due to their potential use in medicine and agriculture.
In this webinar, we will present several examples of interesting studies conducted in Israel on the topic of extravesicles.
Date: 30 October 2025 at 13:00 CET | 20:00 CST Asia
Webinar ID: 871 5071 1183
Webpage: https://sciforum.net/event/Biomedicines-18
Register now for free.
Program:
|
Speaker |
Presentation Title |
Time in CEST |
Time in CST (Asia) |
|
Dr. Orit Uziel (Chair) |
Chair Introduction |
13:00–13:10 |
20:00–20:10 |
|
Dr. Orit Uziel |
Extracellular vesicles in hematological malignancies |
13:10–13:30 |
20:10–20:30 |
|
|
Q&A |
13:30–13:35 |
20:30–20:35 |
|
Dr. Avraham Dayan |
A One-Stop Platform for Comprehensive Extracellular Vesicle Research and Translational Applications |
13:35–13:55 |
20:35–20:55 |
|
|
Q&A |
13:55–14:00 |
20:55–21:00 |
|
Dr. Daniella Levy Erez |
Beyond the Needle: Urinary EVs as Liquid Biopsies in Kidney Transplantation |
14:00–14:20 |
21:00–21:20 |
|
|
Q&A |
14:20–14:25 |
21:20–21:25 |
|
Dr. Orit Uziel |
Webinar Closing |
14:25–14:30 |
21:25–21:30 |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic and institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Orit Uziel, The Felsenstein Medical Research Center, Rabin Medical Center; Gray Faculty of Medical Sciences, Tel-Aviv University;
- Dr. Avraham Dayan, Life Sciences Core Facilities, Weizmann Institute of Science;
- Dr. Daniella Levy Erez, Institute of Nephrology, Schneider Children’s Medical Center of Israel and Felsenstein Research Institute, Tel Aviv University.
Relevant Special Issues:
“Extracellular Vesicles for Diagnosis and Treatment of Human Diseases”
Guest Editor: Dr. Zoran Minic
Deadline for manuscript submissions: 30 November 2025
“The Role of Telomere and Telomerase in Human Disease—2nd Edition”
Guest Editor: Dr. Orit Uziel
Deadline for manuscript submissions: 31 December 2025
13 October 2025
Meet Us at Neuroscience 2025, 15–19 November 2025, San Diego, USA
11 October 2025
World Mental Health Day—“Mental Health in Humanitarian Emergencies”, 10 October 2025
October 10 is World Mental Health Day, and its objective is to raise awareness of mental health issues around the world and to mobilize efforts in support of mental health. The day provides an opportunity for all stakeholders working on mental health issues to talk about their work, and what needs to be achieved to make mental health care a reality for people worldwide.
In recognition of this important day, we recommend the following related articles, Special Issues and journals spanning multidisciplinary fields, including clinical medicine. We believe th.at promoting such research contributes to enhanced public awareness of mental health.
| Medicine & Pharmacology |
|
Environment & Ecology |
Website: https://sciforum.net/event/WMHDW2025
Keynote Speakers:
|
|
|
|
| Professor Nicola Magnavita | Dr. Donatella Rita Petretto | Dr. Marios Adamou |
| Università Cattolica del Sacro Cuore, Italy | University of Cagliari, Italy | University of Huddersfield, United Kingdom |
Free to register for this webinar here!
“Bridging Disciplines: Integrating Mental Health and Education to Promote Immigrant Student Wellbeing”
by Vanja Pejic, Kristin Russo, Rhode Milord-LeBlanc, Kayla Mehjabin Parr, Sara Whitcomb and Robyn S. Hess
Behav. Sci. 2025, 15(9), 1254; https://doi.org/10.3390/bs15091254
“Reattribution of Auditory Hallucinations Throughout Avatar Therapy: A Case Series”
by Sabrina Giguère, Mélissa Beaudoin, Laura Dellazizzo, Kingsada Phraxayavong, Stéphane Potvin and Alexandre Dumais
Reports 2025, 8(3), 113; https://doi.org/10.3390/reports8030113
“New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?”
by Paola Bozzatello, Roberta Novelli, Rebecca Schisano, Claudio Brasso, Paola Rocca and Silvio Bellino
Pharmaceuticals 2025, 18(5), 665; https://doi.org/10.3390/ph18050665
“Public Perceptions of Urban Green Spaces: Effects on Physical and Mental Health”
by Regina Veckalne, Asomkhodja Saidkhodjaev and Tatjana Tambovceva
Urban Sci. 2025, 9(4), 128; https://doi.org/10.3390/urbansci9040128
“Exploring the Role of Guilt in Eating Disorders: A Pilot Study”
by Fabiola Raffone, Danilo Atripaldi, Eugenia Barone, Luigi Marone, Marco Carfagno, Francesco Mancini, Angelo Maria Saliani and Vassilis Martiadis
Clin. Pract. 2025, 15(3), 56; https://doi.org/10.3390/clinpract15030056
“Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications”
by Francesco Weiss, Anna Magnesa, Matteo Gambini, Riccardo Gurrieri, Eric Annuzzi, Camilla Elefante, Giulio Perugi and Donatella Marazziti
Brain Sci. 2025, 15(2), 117; https://doi.org/10.3390/brainsci15020117
“The Mind Under Pressure: What Roles Does Education Play in the Relationship Between Chronic Stress and Cognitive Ability?”
by Maximilian Seitz and Diana Steger
J. Intell. 2025, 13(2), 13; https://doi.org/10.3390/jintelligence13020013
“The Association Between Childhood Experience of Living with a Heavy Drinker and Self-Rated Mental Health in the Adult General Population”
by Danica Romac, Varja Gaić Đogaš, Ljiljana Muslić, Sandro Krašić, Marija Kušan Jukić and Sanja Musić Milanović
Diseases 2025, 13(2), 28; https://doi.org/10.3390/diseases13020028
“Exploring Psychological Distress Among Individuals with Specific Learning Disabilities: The Impact of Age, Gender, and Disability Type”
by Nimrod Polak and Ephraim S. Grossman
Disabilities 2024, 4(4), 1044-1064; https://doi.org/10.3390/disabilities4040065
“Changes in Adolescent Heterosexual Behaviors from the 1980s to the Present in Various Western Countries: A Systematic Review”
by José Luis Martínez-Álvarez, Mᵃ Rosario Pozo-García and Judit García-Martín
Sexes 2024, 5(4), 652-669; https://doi.org/10.3390/sexes5040042
“Incorporating Evidence of Migrant Women with Schizophrenia into a Women’s Clinic”
by Alexandre González-Rodríguez, Bruma Palacios-Hernández, Mentxu Natividad, Leah C. Susser, Jesús Cobo, Elisa Rial, Helena Cachinero, Eduard Izquierdo, Mireia Salvador, Ariadna Balagué et al.
Women 2024, 4(4), 416-434; https://doi.org/10.3390/women4040032
“Early Detection of Mental Health Crises through Artificial-Intelligence-Powered Social Media Analysis: A Prospective Observational Study”
by Masab A. Mansoor and Kashif H. Ansari
J. Pers. Med. 2024, 14(9), 958; https://doi.org/10.3390/jpm14090958
“Single-Item Assessment of Quality of Life: Associations with Well-Being, Mood, Health Correlates, and Lifestyle”
by Joris C. Verster, Emina Išerić, Guusje A. Ulijn, Stephanie M. P. Oskam and Johan Garssen
J. Clin. Med. 2024, 13(17), 5217; https://doi.org/10.3390/jcm13175217
“Definitions of Ageing According to the Perspective of the Psychology of Ageing: A Scoping Review”
by Luca Gaviano, Roberto Pili, Andrea Domenico Petretto, Roberta Berti, Gian Pietro Carrogu, Martina Pinna and Donatella Rita Petretto
Geriatrics 2024, 9(5), 107; https://doi.org/10.3390/geriatrics9050107
“Evaluating the Connection between MicroRNAs and Long Non-Coding RNAs for the Establishment of the Major Depressive Disorder Diagnosis”
by Cătălin Prodan-Bărbulescu, Edward Paul Şeclăman, Virgil Enătescu, Ionuţ Flaviu Faur, Laura Andreea Ghenciu, Paul Tuţac, Paul Paşca and Laura Octavia Grigoriţă
Biomedicines 2024, 12(3), 516; https://doi.org/10.3390/biomedicines12030516
“Quality of Life and Incidence of Clinical Signs and Symptoms among Caregivers of Persons with Mental Disorders: A Cross-Sectional Study”
by Vasiliki Oikonomou, Evgenia Gkintoni, Constantinos Halkiopoulos and Evangelos C. Karademas
Healthcare 2024, 12(2), 269; https://doi.org/10.3390/healthcare12020269
|
“Progress and Innovation in the Clinical Management of Psychosis” |
“Molecular Psychiatry and Antipsychotics” |
|
|
|
|
“Current Issues in Cognitive Testing of Older Adults” |
“Job Satisfaction and Mental Health of Workers: Second Edition” |
|
|
|
|
“Innovations in Youth Psychiatry and Psychology: Challenges and Advances” |
“Mental Health Across the Lifespan: Integrating Multidisciplinary Perspectives” |
|
|
|
|
“Mental Health: Clinical Advances in Personalized Medicine” |
“Advances in the Treatment of Depression, Anxiety, and Other Psychiatric Disorders” |
|
|
|
|
“Urban Green Space and Health” |
“Mental Health and the Natural Environment” |
|
|
|
 |
 |
 |
